Clinical trials update 2015: Year in review

被引:0
作者
Peroutka, Stephen J.
机构
[1] PRA International, 26339 Valley View Avenue, Carmel, 93923, CA
来源
HEADACHE | 2016年 / 56卷 / 01期
关键词
clinical trials; headache; update; PREVENTIVE TREATMENT; DOUBLE-BLIND; PHASE; 2B; TOLERABILITY; MULTICENTER; TEV-48125; MIGRAINE; EFFICACY; SAFETY;
D O I
10.1111/head.12744
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This section of Headache annually reviews the status of recently completed and ongoing major clinical trials involving common headache disorders. The review will focus on multicenter trials of new therapies, as well as novel formulations of previously approved therapeutics. The Table summarizes the major therapeutic headache trials that were ongoing at the end of 2015, according to data obtained from both the ClinicalTrials.Gov website and from corporate press releases and presentations.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 2 条
[1]   Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study [J].
Bigal, Marcelo E. ;
Dodick, David W. ;
Rapoport, Alan M. ;
Silberstein, Stephen D. ;
Ma, Yuju ;
Yang, Ronghua ;
Loupe, Pippa S. ;
Burstein, Rami ;
Newman, Lawrence C. ;
Lipton, Richard B. .
LANCET NEUROLOGY, 2015, 14 (11) :1081-1090
[2]   Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study [J].
Bigal, Marcelo E. ;
Edvinsson, Lars ;
Rapoport, Alan M. ;
Lipton, Richard B. ;
Spierings, Egilius L. H. ;
Diener, Hans-Christoph ;
Burstein, Rami ;
Loupe, Pippa S. ;
Ma, Yuju ;
Yang, Ronghua ;
Silberstein, Stephen D. .
LANCET NEUROLOGY, 2015, 14 (11) :1091-1100